Dennis M. Fenton
CIK: 0001184627
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
Exercise(M)Direct6K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
42K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
15K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
4K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
5.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
5.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
11K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
11K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
9.2K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10.6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
4K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
5.5K shares- - Jun 18, 2025ANAB
ANAPTYSBIO, INC
Sale(S)Direct3K shares at avg. $23.97$72K - Jun 15, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct6K shares- - Jan 7, 2025ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
16.5K shares- - Jan 7, 2025ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise(M) | 6,030 | - | $0 | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 42,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 15,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 6,030 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 6,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 5,507 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 6,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 11,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 11,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 9,200 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 10,600 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Jan 6, 2026 |  ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Jun 18, 2025 | ANAB ANAPTYSBIO, INC | Sale(S) | 3,015 | $23.97 | $72,270 | Direct |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 6,030 | - | - | Direct |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 6,030 | - | - | Direct |
1-23 of 23 transactions
About FENTON DENNIS M
FENTON DENNIS M (SEC CIK 0001184627) files insider reports with the SEC as Director of First Tracks Biotherapeutics, Inc. (TRAX) and Director of ANAPTYSBIO, INC (ANAB).
Signal8 holds 9 ownership filings by FENTON DENNIS M (1 Form 3, 8 Form 4), filed between Jan 7, 2025 and Jun 17, 2026. Those filings report 23 transactions, from Jan 7, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FENTON DENNIS M's filings is in SAN DIEGO, CA.
Recent filings by FENTON DENNIS M
- Jun 15, 2026: Option exercise of TRAX shares (Form 4, code M).
- May 12, 2026: Grants or awards of TRAX derivative securities (4 lines, Form 4, code A).
- Apr 20, 2026: Grants or awards of TRAX derivative securities (12 lines, Form 4, code A).
- Jan 6, 2026: Grants or awards of ANAB derivative securities (2 lines, Form 4, code A).
- Jun 18, 2025: Open-market sale of ANAB shares (Form 4, code S).
Other insiders filing for First Tracks Biotherapeutics, Inc. (TRAX)
- Orwin John A, Director
- Ware J. Anthony, Director
- STONE BENJAMIN, Chief Business Officer
- Lizzul Paul F., Chief Medical Officer
- Faga Daniel, President, CEO
- Jain Rita, Director